Specifically, certain autophagy-related genes, such as Beclin1, LC3, and ATG5, significantly influence the progression of NSCLC by regulating processes like cell death, metabolic reprogramming, and adaptation to the microenvironment, thereby laying the groundwork for developing novel therapeutic strategies [96]. This evidence concerns the gene MAP1LC3A and non-small cell lung carcinoma.